China Feihe Limited (CFEIY) Research
China Feihe Limited functions as an investment holding company, primarily specializing in the manufacturing and distribution of infant milk formula throughout Mainland China and the United States. The firm's product range is extensive, including various milk products such as raw milk, adult milk powders, and liquid milk, alongside a selection of health care products. Furthermore, it supplies specialized options like soybean and goat milk powders. Beyond dairy, China Feihe also engages in the retail of a wide array of nutritional supplements, including vitamins, minerals, and herbal products. Its sales strategy utilizes multiple channels, reaching customers through a network of distributors, prominent e-commerce platforms like Tmall, JD.com, and Suning.com, and directly via its corporate website and mobile applications, notably WeChat. As of December 31, 2021, the company maintained a substantial offline distribution infrastructure, serving approximately 2,000 direct customers who, in turn, managed a vast network of 110,000 retail points of sale. Established in 1962, China Feihe Limited has its corporate headquarters located in Beijing, People's Republic of China.
Market snapshot
- Symbol
- CFEIY
- Price
- $4.39
- Day change
- 0.00%
- Market cap
- $23.8B
- P/E ratio
- 12.71x
- 52-week range
- 4.388-8.1
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
Peer companies
Open China Feihe Limited (CFEIY) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.